Dupuytren's disease: current state of the art.
Mark Henry
https://pubmed.ncbi.nlm.nih.gov/24570630/Actively Recruiting
Led by Elsan · Updated on 2026-04-23
172
Participants Needed
2
Research Sites
156 weeks
Total Duration
Dupuytrens disease is a common hereditary condition in Northern Europe that causes progressive fibrosis in the hands palmar aponeurosis. This fibrosis leads to bending of the fingers, resulting in significant functional impairment. Various medical and surgical treatments exist, but none fully prevent recurrence of the disease. This trial investigates whether adding autologous adipose tissue grafting to open aponeurectomy can reduce the 2-year recurrence rate of Dupuytrens disease compared to aponeurectomy alone. The study compares two groups one receiving standard open aponeurectomy alone and the other receiving aponeurectomy combined with adipose tissue grafting. The grafting involves harvesting fat from the arm and injecting it into areas where fibrotic cords were removed, aiming to reconstruct tissue and potentially inhibit fibrosis. Both procedures are performed under anesthesia and follow standard surgical safety practices. Participants will be monitored over several years to assess recurrence rates at 2, 3, and 5 years after surgery. Other evaluations include scar appearance, complication rates shortly after surgery, occurrence of algodystrophy, and quality of life impacts at multiple time points. Researchers will conduct follow-up visits to collect data on these outcomes and overall safety, with participant involvement lasting up to five years post intervention.
CONDITIONS
Efficacy of Aponeurectomy on the 2-year Recurrence Rate of Dupuytren's Disease
E
Elias SAWAYA, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Elsan
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 week
Participants undergo aponeurectomy surgery either with or without adipose tissue grafting to treat Dupuytren's disease.
1 surgical visit and 1 follow-up visit within 1 week after surgery
Duration - Up to 5 years after surgery
Participants are monitored for complications, scar appearance, occurrence of algodystrophy, and quality of life after surgery.
Visits at 6 weeks, 6 months, 1 year, 2 years, 3 years, and 5 years after surgery
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Mark Henry
https://pubmed.ncbi.nlm.nih.gov/24570630/Hester J Kan, Frank W Verrijp, Steven E R Hovius...
https://pubmed.ncbi.nlm.nih.gov/28505187/Sydney R Coleman
https://pubmed.ncbi.nlm.nih.gov/16936550/Christina Engstrand, Barbro Krevers, Göran Nylander...
https://pubmed.ncbi.nlm.nih.gov/24969497/Ali Mojallal, Charlotte Lequeux, Christo Shipkov...
https://pubmed.ncbi.nlm.nih.gov/19730294/Ruud W Selles, Chao Zhou, Hester J Kan...
https://pubmed.ncbi.nlm.nih.gov/30489526/Paul E Mintken, Paul Glynn, Joshua A Cleland
https://pubmed.ncbi.nlm.nih.gov/19297202/Jennifer S N Verhoekx, Vivek Mudera, Erik T Walbeehm...
https://pubmed.ncbi.nlm.nih.gov/23924646/Elias T Sawaya, Benjamin Sommier, Jean-Maxime Alet...
https://pubmed.ncbi.nlm.nih.gov/39223657/Dorcas E Beaton, James G Wright, Jeffrey N Katz...
https://pubmed.ncbi.nlm.nih.gov/15866967/Elsan
Lead Sponsor